Muscular Dystrophies: all 550 studies
Page 6 of 6. Open to participants first (89), then studies with results posted, then the rest; newest registration first within each.
- Tadalafil and Sildenafil for Duchenne Muscular DystrophyCompletedNCT01359670Early Phase 1
- Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy PatientsCompletedNCT01350154Phase 2
- Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2CCompletedNCT01344798Phase 1
- Safety Study of Flavocoxid in Duchenne Muscular DystrophyCompletedNCT01335295Phase 1
- Extension Study of ACE-031 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01239758Phase 2
- Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyCompletedNCT01183767Phase 2/3
- The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry SponsorCompletedNCT01182324
- Dysphagia in Oculopharyngeal Muscular Dystrophy (OPMD)- Evaluation, Endoscopic Examination of Swallowing, Treatment and Long Term Follow upStatus unknownNCT01167439Phase 1
- Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular DystrophyCompletedNCT01153932Phase 2
- A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD SubjectsCompletedNCT01128855Phase 1
- Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular DystrophiesCompletedNCT01126697Phase 2/3
- Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)CompletedNCT01125709
- Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy PatientsCompletedNCT01116570Not applicable
- This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular DystrophyCompletedNCT01098708
- Cardiac Magnetic Resonance in Children With Muscular DystrophyCompletedNCT01081080
- Tadalafil in Becker Muscular DystrophyCompletedNCT01070511Phase 4
- Cardiac Outcome Measures in Children With Muscular DystrophyCompletedNCT01066455
- Evaluation of Limb-Girdle Muscular DystrophyCompletedNCT00893334
- A Randomized Exercise Trial for Wheelchair UsersCompletedNCT00866112Not applicable
- Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy PatientsCompletedNCT00821548Not applicable
- Ramipril Versus Carvedilol in Duchenne and Becker PatientsStatus unknownNCT00819845Phase 4
- Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of MyoblastsCompletedNCT00773227Phase 2
- Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)CompletedNCT00758225Phase 2
- The Efficacy of Using Far Infrared Radiation to Manage Muscular DystrophiesStatus unknownNCT00674843Phase 1
- Arrhythmias in Myotonic Muscular DystrophyCompletedNCT00622453
- The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular DystrophyStatus unknownNCT00606775Phase 4
- The Cardiovascular Genetic and Therapeutic Implications of Muscular DystrophyStatus unknownNCT00518817
- Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)CompletedNCT00494195Phase 1
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)Status unknownNCT00468832
- Genetic Characterization of Individuals With Limb Girdle Muscular DystrophyCompletedNCT00457912
- Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop CodonsCompletedNCT00451074Phase 1
- Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular DystrophyCompletedNCT00428935Phase 1
- Biomechanical Analysis of Gait in Individuals With Duchenne Muscular DystrophyCompletedNCT00312247
- Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular DystrophyCompletedNCT00296621Phase 2
- Safety and Efficacy Study of PTC124 in Duchenne Muscular DystrophyCompletedNCT00264888Phase 2
- Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular DystrophyCompletedNCT00243789Phase 1/2
- Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular DystrophyWithdrawnNCT00207857
- High-dose Prednisone in Duchenne Muscular DystrophyCompletedNCT00110669Phase 3
- Pentoxifylline in Duchenne Muscular DystrophyCompletedNCT00102453Phase 1/2
- KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular DystrophyCompletedNCT00033813Phase 2
- An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular DystrophyCompletedNCT00033189Phase 2
- Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)CompletedNCT00027391Not applicable
- A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)CompletedNCT00018109Phase 3
- Creatine and Glutamine in Steroid-Naive Duchenne Muscular DystrophyCompletedNCT00016653Phase 2/3
- Gentamicin Treatment of Muscular DystrophyCompletedNCT00005574Phase 1
- Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic DystrophyCompletedNCT00004769
- Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular DystrophyCompletedNCT00004685Not applicable
- Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular DystrophyCompletedNCT00004646Phase 3
- Study of Muscle Abnormalities in Patients With Specific Genetic MutationsCompletedNCT00001871
- Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal VolunteersCompletedNCT00001164